Global Bioengineered Protein Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Bioengineered Protein Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Bioengineered Protein Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Bioengineered Protein Drugs by Country/Region, 2017, 2022 & 2028

2.2 Bioengineered Protein Drugs Segment by Type

2.2.1 Monoclonal Antibodies

2.2.2 Therapeutic Proteins

2.2.3 Vaccines

2.3 Bioengineered Protein Drugs Sales by Type

2.3.1 Global Bioengineered Protein Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Bioengineered Protein Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Bioengineered Protein Drugs Sale Price by Type (2017-2022)

2.4 Bioengineered Protein Drugs Segment by Application

2.4.1 Cancer

2.4.2 Diabetes

2.4.3 Autoimmune Disorder

2.4.4 Infectious Disease

2.4.5 Neurodegenerative

2.4.6 Others

2.5 Bioengineered Protein Drugs Sales by Application

2.5.1 Global Bioengineered Protein Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Bioengineered Protein Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Bioengineered Protein Drugs Sale Price by Application (2017-2022)

3 Global Bioengineered Protein Drugs by Company

3.1 Global Bioengineered Protein Drugs Breakdown Data by Company

3.1.1 Global Bioengineered Protein Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Bioengineered Protein Drugs Sales Market Share by Company (2020-2022)

3.2 Global Bioengineered Protein Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Bioengineered Protein Drugs Revenue by Company (2020-2022)

3.2.2 Global Bioengineered Protein Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Bioengineered Protein Drugs Sale Price by Company

3.4 Key Manufacturers Bioengineered Protein Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Bioengineered Protein Drugs Product Location Distribution

3.4.2 Players Bioengineered Protein Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Bioengineered Protein Drugs by Geographic Region

4.1 World Historic Bioengineered Protein Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Bioengineered Protein Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Bioengineered Protein Drugs Annual Revenue by Geographic Region

4.2 World Historic Bioengineered Protein Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Bioengineered Protein Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Bioengineered Protein Drugs Annual Revenue by Country/Region

4.3 Americas Bioengineered Protein Drugs Sales Growth

4.4 APAC Bioengineered Protein Drugs Sales Growth

4.5 Europe Bioengineered Protein Drugs Sales Growth

4.6 Middle East & Africa Bioengineered Protein Drugs Sales Growth

5 Americas

5.1 Americas Bioengineered Protein Drugs Sales by Country

5.1.1 Americas Bioengineered Protein Drugs Sales by Country (2017-2022)

5.1.2 Americas Bioengineered Protein Drugs Revenue by Country (2017-2022)

5.2 Americas Bioengineered Protein Drugs Sales by Type

5.3 Americas Bioengineered Protein Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Bioengineered Protein Drugs Sales by Region

6.1.1 APAC Bioengineered Protein Drugs Sales by Region (2017-2022)

6.1.2 APAC Bioengineered Protein Drugs Revenue by Region (2017-2022)

6.2 APAC Bioengineered Protein Drugs Sales by Type

6.3 APAC Bioengineered Protein Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Bioengineered Protein Drugs by Country

7.1.1 Europe Bioengineered Protein Drugs Sales by Country (2017-2022)

7.1.2 Europe Bioengineered Protein Drugs Revenue by Country (2017-2022)

7.2 Europe Bioengineered Protein Drugs Sales by Type

7.3 Europe Bioengineered Protein Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Bioengineered Protein Drugs by Country

8.1.1 Middle East & Africa Bioengineered Protein Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Bioengineered Protein Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Bioengineered Protein Drugs Sales by Type

8.3 Middle East & Africa Bioengineered Protein Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs

10.3 Manufacturing Process Analysis of Bioengineered Protein Drugs

10.4 Industry Chain Structure of Bioengineered Protein Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Bioengineered Protein Drugs Distributors

11.3 Bioengineered Protein Drugs Customer

12 World Forecast Review for Bioengineered Protein Drugs by Geographic Region

12.1 Global Bioengineered Protein Drugs Market Size Forecast by Region

12.1.1 Global Bioengineered Protein Drugs Forecast by Region (2023-2028)

12.1.2 Global Bioengineered Protein Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Bioengineered Protein Drugs Forecast by Type

12.7 Global Bioengineered Protein Drugs Forecast by Application

13 Key Players Analysis

13.1 Dr.Reddy’s

13.1.1 Dr.Reddy’s Company Information

13.1.2 Dr.Reddy’s Bioengineered Protein Drugs Product Offered

13.1.3 Dr.Reddy’s Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Dr.Reddy’s Main Business Overview

13.1.5 Dr.Reddy’s Latest Developments

13.2 Eli Lilly

13.2.1 Eli Lilly Company Information

13.2.2 Eli Lilly Bioengineered Protein Drugs Product Offered

13.2.3 Eli Lilly Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Eli Lilly Main Business Overview

13.2.5 Eli Lilly Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Bioengineered Protein Drugs Product Offered

13.3.3 Merck Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Reliance Life Sciences

13.4.1 Reliance Life Sciences Company Information

13.4.2 Reliance Life Sciences Bioengineered Protein Drugs Product Offered

13.4.3 Reliance Life Sciences Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Reliance Life Sciences Main Business Overview

13.4.5 Reliance Life Sciences Latest Developments

13.5 Panacea Biotech

13.5.1 Panacea Biotech Company Information

13.5.2 Panacea Biotech Bioengineered Protein Drugs Product Offered

13.5.3 Panacea Biotech Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Panacea Biotech Main Business Overview

13.5.5 Panacea Biotech Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Bioengineered Protein Drugs Product Offered

13.6.3 Novartis Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 Fresenius

13.7.1 Fresenius Company Information

13.7.2 Fresenius Bioengineered Protein Drugs Product Offered

13.7.3 Fresenius Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Fresenius Main Business Overview

13.7.5 Fresenius Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Bioengineered Protein Drugs Product Offered

13.8.3 Sanofi Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 ProBioGen

13.9.1 ProBioGen Company Information

13.9.2 ProBioGen Bioengineered Protein Drugs Product Offered

13.9.3 ProBioGen Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 ProBioGen Main Business Overview

13.9.5 ProBioGen Latest Developments

13.10 GlaxoSmithKline

13.10.1 GlaxoSmithKline Company Information

13.10.2 GlaxoSmithKline Bioengineered Protein Drugs Product Offered

13.10.3 GlaxoSmithKline Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 GlaxoSmithKline Main Business Overview

13.10.5 GlaxoSmithKline Latest Developments

13.11 Roche

13.11.1 Roche Company Information

13.11.2 Roche Bioengineered Protein Drugs Product Offered

13.11.3 Roche Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Roche Main Business Overview

13.11.5 Roche Latest Developments

13.12 Amoytop Biotech

13.12.1 Amoytop Biotech Company Information

13.12.2 Amoytop Biotech Bioengineered Protein Drugs Product Offered

13.12.3 Amoytop Biotech Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Amoytop Biotech Main Business Overview

13.12.5 Amoytop Biotech Latest Developments

13.13 Shanghai United Cell Biotechnology

13.13.1 Shanghai United Cell Biotechnology Company Information

13.13.2 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product Offered

13.13.3 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Shanghai United Cell Biotechnology Main Business Overview

13.13.5 Shanghai United Cell Biotechnology Latest Developments

13.14 Hualan Bio

13.14.1 Hualan Bio Company Information

13.14.2 Hualan Bio Bioengineered Protein Drugs Product Offered

13.14.3 Hualan Bio Bioengineered Protein Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Hualan Bio Main Business Overview

13.14.5 Hualan Bio Latest Developments

14 Research Findings and Conclusion

Table 1. Bioengineered Protein Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Bioengineered Protein Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Monoclonal Antibodies

Table 4. Major Players of Therapeutic Proteins

Table 5. Major Players of Vaccines

Table 6. Global Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)

Table 7. Global Bioengineered Protein Drugs Sales Market Share by Type (2017-2022)

Table 8. Global Bioengineered Protein Drugs Revenue by Type (2017-2022) & ($ million)

Table 9. Global Bioengineered Protein Drugs Revenue Market Share by Type (2017-2022)

Table 10. Global Bioengineered Protein Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)

Table 12. Global Bioengineered Protein Drugs Sales Market Share by Application (2017-2022)

Table 13. Global Bioengineered Protein Drugs Revenue by Application (2017-2022)

Table 14. Global Bioengineered Protein Drugs Revenue Market Share by Application (2017-2022)

Table 15. Global Bioengineered Protein Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Bioengineered Protein Drugs Sales by Company (2020-2022) & (K Units)

Table 17. Global Bioengineered Protein Drugs Sales Market Share by Company (2020-2022)

Table 18. Global Bioengineered Protein Drugs Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Bioengineered Protein Drugs Revenue Market Share by Company (2020-2022)

Table 20. Global Bioengineered Protein Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Bioengineered Protein Drugs Producing Area Distribution and Sales Area

Table 22. Players Bioengineered Protein Drugs Products Offered

Table 23. Bioengineered Protein Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Bioengineered Protein Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Bioengineered Protein Drugs Sales Market Share Geographic Region (2017-2022)

Table 28. Global Bioengineered Protein Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Bioengineered Protein Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Bioengineered Protein Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Bioengineered Protein Drugs Sales Market Share by Country/Region (2017-2022)

Table 32. Global Bioengineered Protein Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Bioengineered Protein Drugs Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Bioengineered Protein Drugs Sales by Country (2017-2022) & (K Units)

Table 35. Americas Bioengineered Protein Drugs Sales Market Share by Country (2017-2022)

Table 36. Americas Bioengineered Protein Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Bioengineered Protein Drugs Revenue Market Share by Country (2017-2022)

Table 38. Americas Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)

Table 39. Americas Bioengineered Protein Drugs Sales Market Share by Type (2017-2022)

Table 40. Americas Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)

Table 41. Americas Bioengineered Protein Drugs Sales Market Share by Application (2017-2022)

Table 42. APAC Bioengineered Protein Drugs Sales by Region (2017-2022) & (K Units)

Table 43. APAC Bioengineered Protein Drugs Sales Market Share by Region (2017-2022)

Table 44. APAC Bioengineered Protein Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Bioengineered Protein Drugs Revenue Market Share by Region (2017-2022)

Table 46. APAC Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)

Table 47. APAC Bioengineered Protein Drugs Sales Market Share by Type (2017-2022)

Table 48. APAC Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)

Table 49. APAC Bioengineered Protein Drugs Sales Market Share by Application (2017-2022)

Table 50. Europe Bioengineered Protein Drugs Sales by Country (2017-2022) & (K Units)

Table 51. Europe Bioengineered Protein Drugs Sales Market Share by Country (2017-2022)

Table 52. Europe Bioengineered Protein Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Bioengineered Protein Drugs Revenue Market Share by Country (2017-2022)

Table 54. Europe Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)

Table 55. Europe Bioengineered Protein Drugs Sales Market Share by Type (2017-2022)

Table 56. Europe Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)

Table 57. Europe Bioengineered Protein Drugs Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Bioengineered Protein Drugs Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Bioengineered Protein Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Bioengineered Protein Drugs Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Bioengineered Protein Drugs Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Bioengineered Protein Drugs Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Bioengineered Protein Drugs

Table 67. Key Market Challenges & Risks of Bioengineered Protein Drugs

Table 68. Key Industry Trends of Bioengineered Protein Drugs

Table 69. Bioengineered Protein Drugs Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Bioengineered Protein Drugs Distributors List

Table 72. Bioengineered Protein Drugs Customer List

Table 73. Global Bioengineered Protein Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Bioengineered Protein Drugs Sales Market Forecast by Region

Table 75. Global Bioengineered Protein Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Bioengineered Protein Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Bioengineered Protein Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Bioengineered Protein Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Bioengineered Protein Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Bioengineered Protein Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Bioengineered Protein Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Bioengineered Protein Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Bioengineered Protein Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Bioengineered Protein Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Bioengineered Protein Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Bioengineered Protein Drugs Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Bioengineered Protein Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Bioengineered Protein Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Bioengineered Protein Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Bioengineered Protein Drugs Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Bioengineered Protein Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Bioengineered Protein Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 93. Dr.Reddy’s Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 94. Dr.Reddy’s Bioengineered Protein Drugs Product Offered

Table 95. Dr.Reddy’s Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Dr.Reddy’s Main Business

Table 97. Dr.Reddy’s Latest Developments

Table 98. Eli Lilly Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 99. Eli Lilly Bioengineered Protein Drugs Product Offered

Table 100. Eli Lilly Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Eli Lilly Main Business

Table 102. Eli Lilly Latest Developments

Table 103. Merck Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 104. Merck Bioengineered Protein Drugs Product Offered

Table 105. Merck Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Merck Main Business

Table 107. Merck Latest Developments

Table 108. Reliance Life Sciences Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. Reliance Life Sciences Bioengineered Protein Drugs Product Offered

Table 110. Reliance Life Sciences Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Reliance Life Sciences Main Business

Table 112. Reliance Life Sciences Latest Developments

Table 113. Panacea Biotech Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 114. Panacea Biotech Bioengineered Protein Drugs Product Offered

Table 115. Panacea Biotech Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Panacea Biotech Main Business

Table 117. Panacea Biotech Latest Developments

Table 118. Novartis Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 119. Novartis Bioengineered Protein Drugs Product Offered

Table 120. Novartis Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Novartis Main Business

Table 122. Novartis Latest Developments

Table 123. Fresenius Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 124. Fresenius Bioengineered Protein Drugs Product Offered

Table 125. Fresenius Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. Fresenius Main Business

Table 127. Fresenius Latest Developments

Table 128. Sanofi Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 129. Sanofi Bioengineered Protein Drugs Product Offered

Table 130. Sanofi Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Sanofi Main Business

Table 132. Sanofi Latest Developments

Table 133. ProBioGen Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 134. ProBioGen Bioengineered Protein Drugs Product Offered

Table 135. ProBioGen Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. ProBioGen Main Business

Table 137. ProBioGen Latest Developments

Table 138. GlaxoSmithKline Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 139. GlaxoSmithKline Bioengineered Protein Drugs Product Offered

Table 140. GlaxoSmithKline Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 141. GlaxoSmithKline Main Business

Table 142. GlaxoSmithKline Latest Developments

Table 143. Roche Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 144. Roche Bioengineered Protein Drugs Product Offered

Table 145. Roche Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 146. Roche Main Business

Table 147. Roche Latest Developments

Table 148. Amoytop Biotech Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 149. Amoytop Biotech Bioengineered Protein Drugs Product Offered

Table 150. Amoytop Biotech Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 151. Amoytop Biotech Main Business

Table 152. Amoytop Biotech Latest Developments

Table 153. Shanghai United Cell Biotechnology Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 154. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product Offered

Table 155. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 156. Shanghai United Cell Biotechnology Main Business

Table 157. Shanghai United Cell Biotechnology Latest Developments

Table 158. Hualan Bio Basic Information, Bioengineered Protein Drugs Manufacturing Base, Sales Area and Its Competitors

Table 159. Hualan Bio Bioengineered Protein Drugs Product Offered

Table 160. Hualan Bio Bioengineered Protein Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 161. Hualan Bio Main Business

Table 162. Hualan Bio Latest Developments

List of Figures

Figure 1. Picture of Bioengineered Protein Drugs

Figure 2. Bioengineered Protein Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Bioengineered Protein Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Bioengineered Protein Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Bioengineered Protein Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Monoclonal Antibodies

Figure 10. Product Picture of Therapeutic Proteins

Figure 11. Product Picture of Vaccines

Figure 12. Global Bioengineered Protein Drugs Sales Market Share by Type in 2021

Figure 13. Global Bioengineered Protein Drugs Revenue Market Share by Type (2017-2022)

Figure 14. Bioengineered Protein Drugs Consumed in Cancer

Figure 15. Global Bioengineered Protein Drugs Market: Cancer (2017-2022) & (K Units)

Figure 16. Bioengineered Protein Drugs Consumed in Diabetes

Figure 17. Global Bioengineered Protein Drugs Market: Diabetes (2017-2022) & (K Units)

Figure 18. Bioengineered Protein Drugs Consumed in Autoimmune Disorder

Figure 19. Global Bioengineered Protein Drugs Market: Autoimmune Disorder (2017-2022) & (K Units)

Figure 20. Bioengineered Protein Drugs Consumed in Infectious Disease

Figure 21. Global Bioengineered Protein Drugs Market: Infectious Disease (2017-2022) & (K Units)

Figure 22. Bioengineered Protein Drugs Consumed in Neurodegenerative

Figure 23. Global Bioengineered Protein Drugs Market: Neurodegenerative (2017-2022) & (K Units)

Figure 24. Bioengineered Protein Drugs Consumed in Others

Figure 25. Global Bioengineered Protein Drugs Market: Others (2017-2022) & (K Units)

Figure 26. Global Bioengineered Protein Drugs Sales Market Share by Application (2017-2022)

Figure 27. Global Bioengineered Protein Drugs Revenue Market Share by Application in 2021

Figure 28. Bioengineered Protein Drugs Revenue Market by Company in 2021 ($ Million)

Figure 29. Global Bioengineered Protein Drugs Revenue Market Share by Company in 2021

Figure 30. Global Bioengineered Protein Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 31. Global Bioengineered Protein Drugs Revenue Market Share by Geographic Region in 2021

Figure 32. Global Bioengineered Protein Drugs Sales Market Share by Region (2017-2022)

Figure 33. Global Bioengineered Protein Drugs Revenue Market Share by Country/Region in 2021

Figure 34. Americas Bioengineered Protein Drugs Sales 2017-2022 (K Units)

Figure 35. Americas Bioengineered Protein Drugs Revenue 2017-2022 ($ Millions)

Figure 36. APAC Bioengineered Protein Drugs Sales 2017-2022 (K Units)

Figure 37. APAC Bioengineered Protein Drugs Revenue 2017-2022 ($ Millions)

Figure 38. Europe Bioengineered Protein Drugs Sales 2017-2022 (K Units)

Figure 39. Europe Bioengineered Protein Drugs Revenue 2017-2022 ($ Millions)

Figure 40. Middle East & Africa Bioengineered Protein Drugs Sales 2017-2022 (K Units)

Figure 41. Middle East & Africa Bioengineered Protein Drugs Revenue 2017-2022 ($ Millions)

Figure 42. Americas Bioengineered Protein Drugs Sales Market Share by Country in 2021

Figure 43. Americas Bioengineered Protein Drugs Revenue Market Share by Country in 2021

Figure 44. United States Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. Canada Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 46. Mexico Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 47. Brazil Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. APAC Bioengineered Protein Drugs Sales Market Share by Region in 2021

Figure 49. APAC Bioengineered Protein Drugs Revenue Market Share by Regions in 2021

Figure 50. China Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Japan Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. South Korea Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Southeast Asia Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 54. India Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Australia Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. Europe Bioengineered Protein Drugs Sales Market Share by Country in 2021

Figure 57. Europe Bioengineered Protein Drugs Revenue Market Share by Country in 2021

Figure 58. Germany Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. France Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. UK Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 61. Italy Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 62. Russia Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. Middle East & Africa Bioengineered Protein Drugs Sales Market Share by Country in 2021

Figure 64. Middle East & Africa Bioengineered Protein Drugs Revenue Market Share by Country in 2021

Figure 65. Egypt Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. South Africa Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Israel Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 68. Turkey Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 69. GCC Country Bioengineered Protein Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 70. Manufacturing Cost Structure Analysis of Bioengineered Protein Drugs in 2021

Figure 71. Manufacturing Process Analysis of Bioengineered Protein Drugs

Figure 72. Industry Chain Structure of Bioengineered Protein Drugs

Figure 73. Channels of Distribution

Figure 74. Distributors Profiles